⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL14894731 | 0.95 | — | — | |
| Dimethylamine SCHEMBL7893155 | 0.78 | — | — | |
| Dimethylamine SCHEMBL9854037 | 0.78 | ALDH1A1 (0.56) | — | |
| Dimethylamine SCHEMBL28098217 | 0.78 | ALDH1A1 (0.56) | — | |
| Dimethylamine SCHEMBL10821635 | 0.74 | — | — | |
| Dimethylamine SCHEMBL27962927 | 0.74 | — | — | |
| SCHEMBL5802904 | 0.74 | — | — | |
| SCHEMBL7725 | 0.71 | — | — | |
| SCHEMBL2556849 | 0.71 | — | — | |
| SCHEMBL25152893 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115916221-A | Anticancer activity of perborate | 阿利亚制药公司 | 2023-04-04 | — | — | CN | claimed |
| US-12630582-B2 | Method for biomaterial purification and kits thereof | Life Technologies Corporation (US) | 2026-05-19 | — | — | US | disclosed |
| US-20250235390-A1 | Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-07-24 | — | — | US | disclosed |
| EP-3534866-B1 | METHOD OF DENTAL RETRACTION WITH COMPOSITION WITH GUANIDINYL-CONTAINING POLYMER | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-05-28 | — | — | EP | disclosed |
| US-12295369-B2 | Articles containing a crosslinked guanidinyl-containing polymer and uses thereof | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-05-13 | — | — | US | disclosed |
| US-20250082440-A1 | Composition for Isolating Tissue | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-03-13 | — | — | US | disclosed |
| CN-118557750-A | Methods of treating diffuse large B-cell lymphomas using anti-CD 79B immunoconjugates | 基因泰克公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-118557751-A | Methods of treating diffuse large B-cell lymphomas using anti-CD 79B immunoconjugates | 基因泰克公司 | 2024-08-30 | — | — | CN | disclosed |
| EP-4419062-A1 | COMPOSITION AND PROCESS FOR TREATING A DISORDER IN THE ORAL CAVITY OF A MAMMAL | Solventum Intellectual Properties Company (US) | 2024-08-28 | — | — | EP | disclosed |
| EP-4380494-A1 | COMPOSITION FOR ISOLATING TISSUE | Solventum Intellectual Properties Company (US) | 2024-06-12 | — | — | EP | disclosed |
| WO-2000056712-A1 | SULFONAMIDE DERIVATIVES AS 5-HT7 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 2000-09-28 | — | — | WO | disclosed |
| CN-1092779-A | The compound that can be used as the bone target medicine that has estrin structure | INST OF PHARMACOLOGY (CN) | 1994-09-28 | — | — | CN | disclosed |
| EP-0388309-B1 | 1H,3H,7-pyrrolo [1,2-c] thiazolecarboxamides, their preparation and pharmaceutical compositions containing them | RHONE POULENC SANTE (FR) | 1994-03-02 | — | — | EP | disclosed |
| EP-0561861-A1 | A PROCESS FOR THE PREPARATION OF DILTIAZEM. | LUSOCHIMICA SPA (IT) | 1993-09-29 | — | — | EP | disclosed |
| EP-0388309-A2 | 1H,3H,7-pyrrolo [1,2-c] thiazolecarboxamides, their preparation and pharmaceutical compositions containing them | RHONE-POULENC SANTE (FR) | 1990-09-19 | — | — | EP | disclosed |
| US-4014883-A | ANTITUMOR AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1977-03-29 | — | — | US | disclosed |
| US-3989844-A | Basic oximes and their preparation | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-02 | — | — | US | disclosed |
| US-3969392-A | PARASITICIDE, BACTERICIDE, ANTIINFLAMMATORY, SURFACTANT | E. R. SQUIBB & SONS, INC. (US) | 1976-07-13 | — | — | US | disclosed |
| US-3963778-A | Basic oximes and their preparation | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-15 | — | — | US | disclosed |
| US-3935230-A | α, α, α, α', α', α'-Hexafluorodi-m-tolylamine derivatives | E. R. SQUIBB & SONS, INC. (US) | 1976-01-27 | — | — | US | disclosed |